Clinical and economic impact of common multidrug-resistant gram-negative bacilli.
Giske
Christian G
CG
Clinical Microbiology L2:02, Karolinska Institutet-MTC, Karolinska University Hospital Solna, Stockholm SE-17176, Sweden. christian.giske@karolinska.se
Monnet
Dominique L
DL
Cars
Otto
O
Carmeli
Yehuda
Y
D000150:Acinetobacter / Q000187:drug effects; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D016022:Case-Control Studies; D015331:Cohort Studies; D024901:Drug Resistance, Multiple, Bacterial; D004926:Escherichia coli / Q000187:drug effects; D006090:Gram-Negative Bacteria / Q000145:classification / Q000187:drug effects*; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy / Q000191:economics / Q000382:microbiology / Q000401:mortality; D017721:Hospital Costs; D006801:Humans; D007711:Klebsiella pneumoniae / Q000187:drug effects; D007902:Length of Stay; D011550:Pseudomonas aeruginosa / Q000187:drug effects
D000900:Anti-Bacterial Agents